Ranbaxy Laboratories Ltd has on November 23, 2012 issued 5,000 Secured 9.20% Redeemable Non-Convertible Debentures of face value of Rs. 10,00,000/- each, for cash at par, aggregating Rs. 500 Crores, on a private placement basis, for general corporate purposes. These Debentures have been rated AA+ by CARE and are proposed to be listed on National Stock Exchange of India Ltd. (NSE).
The Ranbaxy Laboratories Ltd stock was trading at Rs.495.95, down by Rs.16.75 or 3.27%. The stock hit an intraday high of Rs.514.95 and low of Rs.491.25.
The total traded quantity was 1.92 lakhs compared to 2 week average of 0.74 lakhs.